BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2017
View Archived Issues
Hope Biosciences acquires rights to nuc-gemcitabine from AptaBio
Read More
JNK1 as a novel therapeutic target for anxiety and depressive-like disorders
Read More
AbbVie begins phase II trials of anti-tau antibody
Read More
Aldeyra Therapeutics gives update on phase III program for ADX-102
Read More
Relmada Therapeutics cleared to conduct phase IIa study of d-methadone for depression
Read More
First-in-human data for 10-1074 in HIV-1-infected individuals
Read More
Phase II data shows superior efficacy of pritelivir over valacyclovir against genital HSV-2
Read More
Johnson & Johnson to acquire Actelion
Read More
DelMar and MD Anderson begin phase II study of VAL-083 in glioblastoma
Read More
Merck KGaA reports findings from phase Ib study of M-1095 in psoriasis
Read More
Gilead describes new Tpl-2/Cot inhibitors
Read More
Zhejiang Hisun Pharmaceutical patents glucagon receptor antagonists
Read More
Ossianix receives milestone payment from Lundbeck
Read More
Neovia initiates phase I trial of NEV-801 in advanced cancers
Read More
Cue Biopharma announces invested capital to develop next-generation biologics
Read More
Lundbeck discovers novel PDE9 inhibitors
Read More
Bayer Pharma presents new bromodomain-containing protein 4 inhibitors
Read More
Galleon Pharmaceuticals divulges new breathing control modulating compounds
Read More
Sumitomo Dainippon Pharma completes acquisition of Tolero Pharmaceuticals
Read More
Verapamil studied in patients with chronic rhinosinusitis with nasal polyps
Read More
Heidelberg Pharma signs license agreement with Max Delbruck Center
Read More